Matches in SCALES for { <http://schemas.scales-okn.org/rdf/scales#/DocketEntry/cod;;1:16-cv-00581_de158> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- cod;;1:16-cv-00581_de158 RegisterActionDate "2017-03-08" @default.
- cod;;1:16-cv-00581_de158 RegisterActionDescriptionText "ORDER denying 136 MOTION in Limine TO EXCLUDE REFERENCE TO ANY PRESCRIBED MEDICATIONS OF MS. F2EE1B1 INCLUDING AS IT RELATES TO ANY IMPACT OF MS. F2EE1B1 PRESCRIBED MEDICATIONS ON HER BEHAVIOR. As with defendant's drug use, If defendant can show through properly disclosed expert testimony by a qualified health care professional that the defendant's drug use on the day of the incident probably affected either her ability to recall the incident accurately or other relevant behaviors, that testimony will be permitted. Moreover, the Court would not permit such expert testimony without a showing of the relevance and reliability of the expert testimony under Rule 702 at a pretrial evidentiary "Daubert" hearing at which the witness testifies in person and is subject to cross-examination. See ruling on ECF No. 126. By Judge R. Brooke Jackson on 3/8/17. Text Only Entry (rbjsec. ) (Entered: 03/08/2017)" @default.
- cod;;1:16-cv-00581_de158 AdministrativeID "159" @default.
- cod;;1:16-cv-00581_de158 OntologyLabel order @default.
- cod;;1:16-cv-00581_de158 hasReferenceToOtherEntry cod;;1:16-cv-00581_de135 @default.